Jackson Medical Mall - UMMC Clinics
Return to Locations Search
Address:
350 Woodrow Wilson Drive
Jackson, MS 39213
Parking:
Parking available at the complex.
Directions:
Driving west on Woodrow Wilson, turn right onto Bailey Avenue and then left into the Jackson Medical Mall complex.
Our Care Specialties at this location:
Our Providers who practice at this location:
| Provider | Specialty Keywords | ||||||
|---|---|---|---|---|---|---|---|
|
Practice Locations:
|
dialysis, stones, nephrologist, renal | ||||||
|
Practice Locations:
|
sexually transmitted, hepatitis, hiv, chlamydia, lyme disease, sti, hep b, vaccination, malaria, west nile, communicable, std, contagious, gonorrhea, hep c | ||||||
|
Practice Locations:
|
sexually transmitted, hepatitis, hiv, chlamydia, lyme disease, sti, hep b, vaccination, malaria, west nile, communicable, std, contagious, gonorrhea, hep c | ||||||
Robert T. Brodell, MDSpecialties:
Dermatopathology (Skin Diseases), Dermatopathology, Melanoma and Skin Cancers
View Practice Locations
Practice Locations:
|
skin, pathologist, pathology, dermatologist, disease, dermatology, derm, dermatologist, tissue samples, skin, dermatology, basal cell, neurofibromatosis, metastasis, cutaneous lymphoma, mohs surgery, neuroblastoma, carcinoma, renal cell carcinoma, squamous, osteosarcoma, sarcoma | ||||||
|
Practice Locations:
|
sexually transmitted, hepatitis, hiv, chlamydia, lyme disease, sti, hep b, vaccination, malaria, west nile, communicable, std, contagious, gonorrhea, hep c | ||||||
|
Practice Locations:
|
sexually transmitted, hepatitis, hiv, chlamydia, lyme disease, sti, hep b, vaccination, malaria, west nile, communicable, std, contagious, gonorrhea, hep c | ||||||
|
Practice Locations:
|
obgyn, pregnancy and childbirth, adolescent gynecology, fallopian tube, female, ovarian, pap smear, obstetrics, reproductive endocrinology and infertility, gynecologist, breast, prenatal classes, endometriosis, vaginal, vulvar, fertility, maternal-fetal, pelvic, menopause management, gynecologist, gynecological, women's health care, pap smear, gynocologist, obstetrician, ob gyn | ||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
|||||||
Ike I. Eriator, MDSpecialties:
General Anesthesiology, Chronic Pain Management
View Practice Locations
Practice Locations:
|
anesthesiologist, anesthetic, anesthesia, anaesthesia, fibromyalgia, pinched nerve, sciatica | ||||||
|
Practice Locations:
|
dialysis, stones, nephrologist, renal | ||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
obgyn, pregnancy and childbirth, adolescent gynecology, fallopian tube, female, ovarian, pap smear, obstetrics, reproductive endocrinology and infertility, gynecologist, breast, prenatal classes, endometriosis, vaginal, vulvar, fertility, maternal-fetal, pelvic, menopause management, ob gyn, pregnant, obstetrician, gynecologist, gynecological, women's health care, pap smear, gynocologist, obstetrician, ob gyn | ||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
sexually transmitted, hepatitis, hiv, chlamydia, lyme disease, sti, hep b, vaccination, malaria, west nile, communicable, std, contagious, gonorrhea, hep c | ||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
teeth, cleaning, veneer, cavity, tooth, crown, filling, gum, mouth, oral | ||||||
|
Practice Locations:
|
dialysis, stones, nephrologist, renal | ||||||
|
Practice Locations:
|
speech therapist, articulation disorder, speech language pathologist, therapy, language pathologist, voice disorder, speech, tep, pathologist, language therapy, pediatric speech therapy, delay disorder, ent speech language pathology, oral myofunctional disorder, voice, ent slp, language disorder, cognition, lymphadema, resonance disorder, language development, speech pathologist, speech, swallowing, language, oral motor | ||||||
|
Practice Locations:
|
sexually transmitted, hepatitis, hiv, chlamydia, lyme disease, sti, hep b, vaccination, malaria, west nile, communicable, std, contagious, gonorrhea, hep c | ||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
ob gyn, pregnant, obstetrician, MFM, maternal, high risk pregnancy, gestational diabetes, amniocentesis, preeclampsia, fetal, ultrasound | ||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
teeth, cleaning, veneer, cavity, tooth, crown, filling, gum, mouth, oral | ||||||
|
Practice Locations:
|
ob gyn, pregnant, obstetrician, MFM, maternal, high risk pregnancy, gestational diabetes, amniocentesis, preeclampsia, fetal, ultrasound | ||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
sexually transmitted, hepatitis, hiv, chlamydia, lyme disease, sti, hep b, vaccination, malaria, west nile, communicable, std, contagious, gonorrhea, hep c | ||||||
|
Practice Locations:
|
fibromyalgia, pinched nerve, sciatica | ||||||
|
Practice Locations:
|
|||||||
Anesh P. Rugnath, MDSpecialties:
General Anesthesiology, Chronic Pain Management
View Practice Locations
Practice Locations:
|
anesthesiologist, anesthetic, anesthesia, anaesthesia, fibromyalgia, pinched nerve, sciatica | ||||||
|
Practice Locations:
|
sexually transmitted, hepatitis, hiv, chlamydia, lyme disease, sti, hep b, vaccination, malaria, west nile, communicable, std, contagious, gonorrhea, hep c | ||||||
|
Practice Locations:
|
speech therapist, articulation disorder, speech language pathologist, therapy, language pathologist, voice disorder, speech, tep, pathologist, language therapy, pediatric speech therapy, delay disorder, ent speech language pathology, oral myofunctional disorder, voice, ent slp, language disorder, cognition, lymphadema, resonance disorder, language development, speech pathologist, speech, swallowing, language, oral motor | ||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
obgyn, pregnancy and childbirth, adolescent gynecology, fallopian tube, female, ovarian, pap smear, obstetrics, reproductive endocrinology and infertility, gynecologist, breast, prenatal classes, endometriosis, vaginal, vulvar, fertility, maternal-fetal, pelvic, menopause management, ob gyn, pregnant, obstetrician, gynecologist, gynecological, women's health care, pap smear, gynocologist, obstetrician, ob gyn | ||||||
|
Practice Locations:
|
fibromyalgia, pinched nerve, sciatica | ||||||
|
Practice Locations:
|
dialysis, stones, nephrologist, renal | ||||||
|
Practice Locations:
|
sexually transmitted, hepatitis, hiv, chlamydia, lyme disease, sti, hep b, vaccination, malaria, west nile, communicable, std, contagious, gonorrhea, hep c | ||||||
|
Practice Locations:
|
bipolar, psychologist | ||||||
|
Practice Locations:
|
sexually transmitted, hepatitis, hiv, chlamydia, lyme disease, sti, hep b, vaccination, malaria, west nile, communicable, std, contagious, gonorrhea, hep c | ||||||
|
Practice Locations:
|
dialysis, stones, nephrologist, renal | ||||||
|
Practice Locations:
|
|||||||
|
Practice Locations:
|
pituitary, insulin, blood sugar, metabolism, thyroid, prediabetes, adrenal, pancreas, neuroendocrine | ||||||
|
Practice Locations:
|
Our Clinical Trials offered at this location:
Researchers at UMMC are committed to discovering innovative ways to prevent and treat the diseases that affect our daily lives. Clinical research studies play a vital role in the advancement of medicine and can improve the well-being of our families, friends, communities, and future generations. In this way, participation in clinical research studies furthers our vision to create "a healthier Mississippi."
Partnering with UMMC’s researchers may have many advantages, including:
- Gaining access to investigational treatments
- Increasing knowledge about your own health
- Giving the gift of improved health to our communities and future generations
- Contributing to the advancement of science by helping researchers learn more about how the human body and mind work or by helping find a cure or better treatments for diseases
| Clinical Trials | Publish Date | Description | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A Clinical Study of the ResistancePlus™ MG Diagnostic Accuracy in Detecting M. genitalium and Mutations Associated with Azithromycin ResistanceIRB Number: 2018-0102
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151520 |
There are currently no standard tests to detect for M. genitalium. Antibiotics used to treat common sexually transmitted infections (STIs) caused by M. genitalium have been found to be resistant. This study will test how well the ResistancePlus™ MG detects M. genitalium and the genes associated with antibiotic resistance. <br> infectious diseases PL-150 Courtney Sims Gomillia lmena Infectious Diseases |
||||||||||||
A Multicenter, Prospective Study of COVID-19 Using Real-Time Syndromic Surveillance, Scheduled At-home Serologic Testing, and Electronic Health RecordsIRB Number: 2020V0238
Published: August 11, 2020
View Locations
Clinical Trial Locations:
|
20200811133248 |
<p>Researchers at UMMC are partnering with UMMC healthcare workers and patients to better understand the spread of COVID-19. Study participants are asked to complete short online questionnaires over several months about possible exposures, symptoms, and healthcare visits. Some volunteers may be asked to complete an in-home test kit for antibodies to COVID-19.</p><p><b>What is the purpose and goal of this study?</b></p><p>As you are aware, the COVID-19 pandemic is a global public health emergency. By studying who has been exposed and possibly infected, better identifying the timing and circumstances of exposure, and where infection patterns of the COVID-19 are advancing, researchers can help the medical community better understand the pandemic and develop strategies and treatments to contain and possibly eliminate it.</p><p><p>The goal of this study is to collect information about the community’s COVID-19 exposures, symptoms, and health care visits due to the disease. If you are a health care worker, the study will collect information on your use of personal protective equipment.</p><p>There is no cost for participating.</p><p>The information collected about you is for research purposes only. This information will not be used to guide your medical care. Your doctor or health care provider will not have access to this information. </p><p>For more information about clinical research study participation, visit <a href="https://umc.edu/Research/Research-Offices/Clinical-Trials/Participants/Home.html">https://umc.edu/Research/Research-Offices/Clinical-Trials/Participants/Home.html</a></p><p><p>For those interested in participating in this trial, please call <a href="tel:16018159522">601-815-9522</a> or email <a href="mailto:COVID19communitystudy@umc.edu">COVID19communitystudy@umc.edu</a></p><p>If you wish to be contacted about participating in the trial, you can also <a href="https://umc.edu/Research/Research-Offices/Clinical-Trials/Participants/Become.html">click here</a> to fill out our general interest form.</p><p>For the Informed
Consent and Enrollment Questionnaire <a href="https://redcap.umc.edu/surveys/?s=3DCAPXRRHT">click here</a><br></p> coronavirus;covid;covid-19 Pending Courtney Gomillia lmena COVID-19 (Coronavirus) |
||||||||||||
A Multicenter,Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Brexanolone in the Treatments of Adolescent Female Subjects with Postpartum Depression.IRB Number: 2019-0255
Published: October 25, 2019
View Locations
Clinical Trial Locations:
|
20191025125433 |
<div>This study will test the effects and safety of brexanolone in adolescent female diagnosed with postpartum depression. </div><div><br></div> depression;pediatrics;women's health 547-PPD-304 Sheila Belk kwallace2 Pediatrics Women's Health |
||||||||||||
A Phase 2a Multiple Ascending, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GFB-887, a TRPC5 Channel Inhibitor, in Patients with Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change DiseaseIRB Number: 2021-1120
Published: March 07, 2022
View Locations
Clinical Trial Locations:
|
20220307105038 |
The purpose of this study is to determine if <span style="color: #0a0a0a;">GFB-887 is a safe and effective treatment for people with high levels of protein in their urine due to Diabetic Nephropathy (DN), Focal Seg</span>mental Glomerulosclerosis (FSGS), and Treatment-Resistant Minimal Change Disease (TR-MCD). GFB-887 is an experimental drug that is not approved by the FDA for the treatment of DN, FSGS, or TR-MCD. goldfinch bio;gfb-887-201;diabetic nephropathy;focal segmental glomerulosclerosis (fsgs);treatment-resistant minimal change disease (tr-mcd) GFB-887-201 Sherrin Dixon tshafi Kidney/Renal Conditions |
||||||||||||
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of SOtagLiflozin on Clinical Outcomes in HemodynamIcally STable Patients with Type 2 Diabetes POST Worsening Heart FailureIRB Number: 2019-0149
Published: June 24, 2019
View Locations
Clinical Trial Locations:
|
20190624162939 |
We are doing this study to learn more about heart failure and diabetes and to see if an FDA approved diabetes medication called sotagliflozin improves cardiovascular outcomes in people with heart failure and diabetes. cardiac;heart;heart health;heart failure EFC15156 Theresa Hickey Hutson cmoore Heart Health |
||||||||||||
All of Us Research ProgramIRB Number: 2018-0109
Published: November 08, 2019
View Locations
Clinical Trial Locations:
|
20191108150347 |
Precision medicine is a revolutionary approach for disease prevention and treatment that takes into account individual differences in lifestyle, environment, and biology. The All of Us Research Program seeks to extend precision medicine to all diseases by building a national research group of one million or more U.S. participants reflecting the rich diversity of the United States. Participants will have access to their results and will work as partners in the research process by maintaining involvement over time and receiving all of their study results. preventive medicine;disease prevention 2017-05 Christina Jordan, PhD cdjordan Preventive Medicine |
||||||||||||
An Open label study to allow patients continuous use of Hemocare hemodialysis system for home hemodialysis prior to market authorizationIRB Number: 2021V0792
Published: March 21, 2022
View Locations
Clinical Trial Locations:
|
20220321181949 |
The purpose of this research study is to allow patient to continue to use the HemoCare Hemodialysis System for Home Hemodialysis. dkpl-00674-001;end stage renal failure DKPL-00674-001 Delia Y. Owens tshafi Kidney/Renal Conditions |
||||||||||||
Autonomic Retulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction (ANTHEM-HFrEF)IRB Number: 2018-0176
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151856 |
The purpose of this study is to see if a new investigational device called the VITARIA system is safe and effective in treating heart failure.<br> heart ANTHEM-HFrEF Theresa Hickey Hutson rlong Heart Health |
||||||||||||
Biobank MississippiIRB Number: 2016-0333
Published: September 14, 2023
View Locations
Clinical Trial Locations:
|
20230914081138 |
This proposal defines the plans for creation of a new resource for future research that will be available to all investigators at University of Mississippi Medical Center (UMMC) and Mayo Clinic (Mayo) through this joint project. We propose to recruit and enroll 10,000 participants. Participants will provide a blood sample for DNA, cells, and serum/plasma, complete a health questionnaire, and allow access to historical and future medical record data. assessment;biospecimens;healthy volunteer BIOBANK MISSISSIPPI Gouri J Mahajan, PhD gmahajan Genetics |
||||||||||||
EMPERIAL STUDY: EMPagliflozin 10 mg compared with placebo on ExeRcise ability and heart failure symptoms, In patients with chronic HeArt FaiLure with preserved Ejection Fraction (HFpEF)IRB Number: 2019-0006
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528133434 |
The purpose of this study is to learn more about heart failure with preserved ejection fraction which is a type of heart failure and means the heart is not working as well as it should. We also want to see if an experimental medication called empagliflozin helps improve heart failure symptoms and patients' quality of life. <br> heart 1245-0167 Theresa Hickey Hutson rlong Heart Health |
||||||||||||
GOG 0263 A Randomized phase III Clinical Trial of Adjuvant Radiation versus Chemoradiation in Intermediate Risk, Stage I/II A Cervical cancer Treated With Initial Radical Hysterectomy and Pelvic LymphadenectomyIRB Number: 2010-0249
Published: July 30, 2019
View Locations
Clinical Trial Locations:
|
20190730154229 |
The purpose of this study is to find out if weekly cisplatin and concurrent radiation therapy increases the time participant's time without disease compared to radiation therapy alone. cancer GOG 0263 Jennifer Barnes kjeanes Cancer |
||||||||||||
Shared Decision Making for Stroke Prevention in Atrial FibrillationIRB Number: 2018-0104
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151617 |
This study is to see if a conversation tool called the "Anticoagulation Choice Conversation Tool" will help participants and their doctors with discussing treatment choices and adherence to therapy in patients with atrial fibrillation (AF) who are at risk for stroke.<br> stroke;brain;atrial fibrillation SDM4Afib Theresa Hickey Hutson tsuzuki Stroke/Traumatic Brain Injury |
||||||||||||
Strategic MAnagement to Improve CRT Using Multi-Site Pacing (SMART-MSP)IRB Number: 2018-0066
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528145708 |
We are doing this study to learn more about the safety and effectiveness of pacing features in the Boston Scientific Resonate pacemakers in patients with heart failure according to the device's approved labeling and after Food and Drug Administration approval of the device.<br> heart C1918 Theresa Hickey Hutson tsuzuki Heart Health |
||||||||||||
The Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), and Chlamydia trachomatis (CT) in WomenIRB Number: 2019-0074
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528113911 |
This study will use vaginal swabs to assess the performance of the Click Diagnostics point-of-care, single-use device for the detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). <br> infectious diseases;pediatrics;women's health 18-0024 Jennifer Brumfield lmena Infectious Diseases Pediatrics Women's Health |
||||||||||||
ToRsemide compArisoN with furoSemide FOR Management of Heart FailureIRB Number: 2018-0117
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151645 |
We are doing this study to learn more about loop diuretic pills (water pills), and to see which one works better in people who have heart failure. <br> heart;heart health;heart failure NCT03296813 Connie Watson mehall Heart Health |
||||||||||||
Vitamin D Supplementation in Children with Obesity-Related Asthma (VDORA1)IRB Number: 2019-0090
Published: June 28, 2019
View Locations
Clinical Trial Locations:
|
20190628094919 |
The purpose of the study is to learn more about Vitamin D levels in children who have asthma and are overweight or obese. pediatrics 228446 Lacy Malloch djosey Pediatrics Weight Management |